Nahide Onsun Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

1/2023	Comparison of Survival and Retention Rates between Infliximab and Adalimumab for Psoriasis: 10-Year Experience at a Single Tertiary Center.
5/2022	Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study.
1/2021	Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID-19 pandemic: The real-world experience of a single center.
1/2021	A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.
1/2019	The HLA-Cw12 Allele Is an Important Susceptibility Allele for Psoriasis and Is Associated with Resistant Psoriasis in the Turkish Population.
6/2017	Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
4/2017	Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
1/2015	Atrial conduction abnormalities in patients with psoriasis vulgaris.
1/2015	The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.
1/2014	Epicardial fat thickness in patients with psoriasis vulgaris.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nahide Onsun Research Topics

Disease

11	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 03/2013
3	Insulin Resistance 05/2022 - 05/2012
2	Inflammation (Inflammations) 05/2022 - 09/2017
2	COVID-19 01/2021 - 01/2021
2	Psoriatic Arthritis 01/2021 - 05/2018
2	Chronic Urticaria 11/2020 - 07/2006
2	Eosinophilia 10/2020 - 08/2019
2	Nevus (Nevi) 01/2020 - 04/2017
1	Microstomia 10/2022
1	Scleromyxedema (Lichen Myxedematosus) 10/2022
1	Body Weight (Weight, Body) 05/2022
1	Necrosis 05/2022
1	Weight Gain 05/2022
1	Obesity 05/2022
1	Glucose Intolerance 04/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Fever (Fevers) 08/2019
1	Lymphadenopathy 08/2019
1	Communicable Diseases (Infectious Diseases) 08/2019
1	Edema (Dropsy) 08/2019
1	Exanthema (Rash) 08/2019
1	Hepatitis C 08/2019
1	Chronic Hepatitis C 08/2019
1	Atopic Dermatitis (Atopic Eczema) 06/2017
1	Pigmented Nevus (Melanocytic Nevus) 04/2017
1	Vascular Skin Diseases 03/2017
1	Bullous Pemphigoid (Pemphigoid) 02/2017
1	Acne Vulgaris 01/2017
1	Facial Paralysis (Facial Palsy) 10/2016
1	Fissured Tongue 10/2016
1	Melkersson-Rosenthal Syndrome 10/2016
1	Warts (Wart) 09/2016
1	Poroma 05/2016
1	Tuberculosis (Tuberculoses) 01/2015
1	Burns 09/2014
1	Paralysis (Palsy) 01/2013
1	Arteriovenous Fistula 01/2013
1	Vascular Malformations 01/2013
1	Infections 01/2012
1	Localized Scleroderma (Morphea) 08/2011
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2010
1	Tinea cruris 09/2008
1	Blastomycosis 05/2004
1	Pyoderma 05/2004

Drug/Important Bio-Agent (IBA)

4	C-Reactive ProteinIBA 03/2017 - 03/2013
3	Ustekinumab (CNTO 1275)FDA Link 05/2022 - 02/2017
3	Etanercept (Enbrel)FDA Link 05/2022 - 04/2017
2	Adalimumab (Humira)FDA Link 01/2023 - 05/2022
2	Infliximab (Remicade)FDA Link 01/2023 - 05/2022
2	Immunoglobulin E (IgE)IBA 10/2020 - 04/2010
2	Acitretin FDA Link 06/2017 - 01/2012
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 10/2022
1	LeptinIBA 05/2022
1	AdiponectinIBA 05/2022
1	Tumor Necrosis Factor InhibitorsIBA 05/2022
1	Nicotinamide PhosphoribosyltransferaseIBA 05/2022
1	AdipokinesIBA 05/2022
1	ResistinIBA 05/2022
1	Interleukin-12 (IL 12)IBA 05/2022
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	sinovac COVID-19 vaccineIBA 01/2021
1	Omalizumab (Xolair)FDA Link 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020
1	Eosinophil Cationic ProteinIBA 10/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	peginterferon alfa-2a (Pegasys)FDA Link 08/2019
1	telaprevirIBA 08/2019
1	Ribavirin (Virazole)FDA LinkGeneric 08/2019
1	Serine Proteases (Serine Protease)IBA 08/2019
1	HLA-C Antigens (HLA-C)IBA 01/2019
1	HLA-C*12 antigenIBA 01/2019
1	CytokinesIBA 09/2017
1	Methotrexate (Mexate)FDA LinkGeneric 06/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2017
1	Vitamin D FDA LinkGeneric 06/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2017
1	Whey ProteinsIBA 01/2017
1	Dapsone FDA Link 10/2016
1	Trichloroacetic AcidIBA 09/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	Nitrofurazone (Nitrofural)FDA Link 09/2014
1	Insulin (Novolin)FDA Link 05/2012
1	Proteins (Proteins, Gene)FDA Link 04/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2008
1	isoconazoleIBA 09/2008
1	thyroid microsomal antibodies (TMII)IBA 07/2006
1	AntibodiesIBA 07/2006

Therapy/Procedure

6	Therapeutics 05/2022 - 01/2012
3	Cryotherapy (Therapy, Cold) 09/2016 - 05/2004
1	Biological Therapy 01/2020
1	Drug Therapy (Chemotherapy) 04/2017
1	Chemoprevention 01/2015
1	Renal Dialysis (Hemodialysis) 01/2013
1	Phototherapy (Light Therapy) 08/2011